Nogapendekin alfa inbakicept-pmln plus BCG now covers high-grade papillary-only disease, based on extrapolation from CIS ...
"This FDA approval is an important milestone for physicians treating patients with complex aortic aneurysms," said Jason ...
Proposition 317 would direct state homeland security to target drug cartels. Voters will decide on the legislative referral ...
Elevar Therapeutics and Hengrui Pharma have resubmitted applications to the FDA seeking approval of rivoceranib plus ...
Dutch sales agent SKOOP Media launches new crime label Dutch Noir led by four new Videoland Originals set within the ‘Mocro ...
BridgeBio Pharma maintains a strong buy rating, driven by robust revenue growth and multiple late-stage pipeline catalysts.
WASHINGTON, Oct. 13, 2026 / ProDentim released a label-by-label comparison guide today that sets the genuine ProDentim tablet against the versions sold on marketplaces in September and pairs each ...
WASHINGTON, Oct. 13, 2026 / A label-by-label comparison of the genuine Yu Sleep capsule against the versions sold on marketplaces in September was released today by Yu Sleep, together with the side ...
Results from the trial showed that adding sotatercept-csrk to background therapy reduced the risk of clinical worsening events by 76% in adult patients with PAH diagnosed within the previous year.
Sloan-Kettering Institute gets a $1.5M FDA grant to map therapeutic targets in ultra-rare sarcomas. Learn how it may advance ...
As cold and flu season ramps up, pharmacists are urging people to take a closer look at what’s actually inside ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results